From Oct 12–14, 2025, the 11th National Conference on Cutting-Edge Technologies in Peptide Drug R&D and Large-Scale Manufacturing successfully concluded in Sanya, Hainan.
As a premier platform for academic and industrial exchange in China’s peptide field, this year’s conference focused on frontier technologies and scalable manufacturing solutions. It provided participants with valuable opportunities to gain industry insights, share innovative achievements, connect with industrial resources, and deepen collaborations. The event strongly promoted the integration and innovation of China’s peptide research, development, and production ecosystem.
During the conference, experts and professionals from universities, peptide R&D companies, manufacturing enterprises, and supply-chain service providers across the country gathered to engage in in-depth discussions on advances in peptide research, production technologies, and industry trends.
As a committed innovator in the peptide field,HangZhouGo Top Peptide Biotechactively participated in this influential industry event. The company joined multiple key forums and technical sessions, engaging in meaningful discussions with leading scholars and industry partners to exchange forward-looking perspectives and explore future development directions.

Standing at the forefront of innovation and leveraging this important industry platform, HangZhouGo Top Peptide Biotech continued to shine in the Asian peptide market, strengthening its presence and showcasing its technological capabilities, high-quality manufacturing standards, and global cooperation vision. The company remains dedicated to advancing peptide research and industrialization, and to contributing to the long-term development of the international peptide industry.




